FAM177A1 Disorder is a newly discovered neurodevelopmental disease with neurodegenerative and autoimmune features. Patients with FAM177A1 disorder experience severe developmental issues, behavioral challenges, difficulty walking, seizures, and more. There are currently no precise treatments nor a cure.

Charlotte and Cooper Hawkins, two of the first children diagnosed with FAM177A1 Disorder, inspired the creation of the FAM177A1 Research Fund. Two years ago, at the time of their diagnosis, their family did not know any other patients, and very little was known about FAM177A1, the gene causing their disease.

Today, 13 other FAM177A1 Disorder patients have been identified and researchers are discovering ways this previously understudied gene is vital for health. Meanwhile, science has evolved, making treatments and cures for diseases like our children’s possible.

For rare diseases like ours, the burden of research and development of treatments almost always falls on the patient group.

The FAM177A1 Research Fund is an all-volunteer, family-led 501(c)(3) foundation guided by a board of world-class scientific and medical advisors determined to improve the lives of patients with FAM177A1 Disorder. In addition, our efforts may also contribute to our understanding of more common diseases like Parkinson's, Alzheimer's, and Arthritis.

Your donations will help accelerate the development of potentially life-transforming treatments for FAM177A1 Disorder. You can make a difference!

Information about FAM177A1 Disease